A Cytokine That Is Involved in Immune Responses in Chronic Hepatitis B Virus Patients

Abstract Background: The present research examines the part interleukin-17 (IL-17) plays in the progression of liver disease in people infected with the long-term hepatitis B virus. A proinflammatory cytokine called IL-17, linked to a number of autoimmune disorders, was examined in serum samples tak...

Full description

Saved in:
Bibliographic Details
Main Authors: Noor R. Abady, Zeana Shakir Al-Al Hindi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Medical Journal of Babylon
Subjects:
Online Access:https://doi.org/10.4103/MJBL.MJBL_996_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586490061783040
author Noor R. Abady
Zeana Shakir Al-Al Hindi
author_facet Noor R. Abady
Zeana Shakir Al-Al Hindi
author_sort Noor R. Abady
collection DOAJ
description Abstract Background: The present research examines the part interleukin-17 (IL-17) plays in the progression of liver disease in people infected with the long-term hepatitis B virus. A proinflammatory cytokine called IL-17, linked to a number of autoimmune disorders, was examined in serum samples taken from different participant groups. Objective: The aim of this study is to examine the levels of IL-17 in various participant groups and understand any possible influence on the development and course of liver fibrosis. Materials and Methods: There were four groups in the study: asymptomatic HBsAg carriers (n = 42), chronic hepatitis B (CHB, n = 57), liver cirrhosis (LC, n = 59), and the normal control group (n = 80). an Enzyme-Linked was used to measure the amounts of IL-17, while reverse transcription polymerase chain reaction was used to find IL-17 mRNA in peripheral blood mononuclear cells (PBMC). Results: Liver disorders such as cirrhosis and CHB are associated with elevated levels of IL-17. Both the subjects’ serum and PBMCs showed these elevated IL-17 levels, demonstrating a strong correlation with inflammation. These findings highlight the significant function of IL-17 in the possible management or treatment of a variety of liver-related conditions. Conclusion: The investigation comes to the conclusion that IL-17 levels increase as liver disease severity increases, suggesting that it is involved in the development of fibrosis and the progression of the disease. Gaining insight into the function of IL-17 may help develop more effective therapies for CHB and LC patients. It is crucial to conduct further research in this area to develop tailored therapeutics.
format Article
id doaj-art-1acc8d2df58b4d518b02f9ee7debe362
institution Kabale University
issn 1812-156X
2312-6760
language English
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Medical Journal of Babylon
spelling doaj-art-1acc8d2df58b4d518b02f9ee7debe3622025-01-25T10:14:50ZengWolters Kluwer Medknow PublicationsMedical Journal of Babylon1812-156X2312-67602024-01-0121119119410.4103/MJBL.MJBL_996_23A Cytokine That Is Involved in Immune Responses in Chronic Hepatitis B Virus PatientsNoor R. AbadyZeana Shakir Al-Al HindiAbstract Background: The present research examines the part interleukin-17 (IL-17) plays in the progression of liver disease in people infected with the long-term hepatitis B virus. A proinflammatory cytokine called IL-17, linked to a number of autoimmune disorders, was examined in serum samples taken from different participant groups. Objective: The aim of this study is to examine the levels of IL-17 in various participant groups and understand any possible influence on the development and course of liver fibrosis. Materials and Methods: There were four groups in the study: asymptomatic HBsAg carriers (n = 42), chronic hepatitis B (CHB, n = 57), liver cirrhosis (LC, n = 59), and the normal control group (n = 80). an Enzyme-Linked was used to measure the amounts of IL-17, while reverse transcription polymerase chain reaction was used to find IL-17 mRNA in peripheral blood mononuclear cells (PBMC). Results: Liver disorders such as cirrhosis and CHB are associated with elevated levels of IL-17. Both the subjects’ serum and PBMCs showed these elevated IL-17 levels, demonstrating a strong correlation with inflammation. These findings highlight the significant function of IL-17 in the possible management or treatment of a variety of liver-related conditions. Conclusion: The investigation comes to the conclusion that IL-17 levels increase as liver disease severity increases, suggesting that it is involved in the development of fibrosis and the progression of the disease. Gaining insight into the function of IL-17 may help develop more effective therapies for CHB and LC patients. It is crucial to conduct further research in this area to develop tailored therapeutics.https://doi.org/10.4103/MJBL.MJBL_996_23chronic hepatitis bil17 expressionil17 rna (mrna)liver cirrhosis
spellingShingle Noor R. Abady
Zeana Shakir Al-Al Hindi
A Cytokine That Is Involved in Immune Responses in Chronic Hepatitis B Virus Patients
Medical Journal of Babylon
chronic hepatitis b
il
17 expression
il
17 rna (mrna)
liver cirrhosis
title A Cytokine That Is Involved in Immune Responses in Chronic Hepatitis B Virus Patients
title_full A Cytokine That Is Involved in Immune Responses in Chronic Hepatitis B Virus Patients
title_fullStr A Cytokine That Is Involved in Immune Responses in Chronic Hepatitis B Virus Patients
title_full_unstemmed A Cytokine That Is Involved in Immune Responses in Chronic Hepatitis B Virus Patients
title_short A Cytokine That Is Involved in Immune Responses in Chronic Hepatitis B Virus Patients
title_sort cytokine that is involved in immune responses in chronic hepatitis b virus patients
topic chronic hepatitis b
il
17 expression
il
17 rna (mrna)
liver cirrhosis
url https://doi.org/10.4103/MJBL.MJBL_996_23
work_keys_str_mv AT noorrabady acytokinethatisinvolvedinimmuneresponsesinchronichepatitisbviruspatients
AT zeanashakiralalhindi acytokinethatisinvolvedinimmuneresponsesinchronichepatitisbviruspatients
AT noorrabady cytokinethatisinvolvedinimmuneresponsesinchronichepatitisbviruspatients
AT zeanashakiralalhindi cytokinethatisinvolvedinimmuneresponsesinchronichepatitisbviruspatients